Breaking Down Northrop Grumman Corporation (NOC) Financial Health: Key Insights for Investors

Breaking Down Northrop Grumman Corporation (NOC) Financial Health: Key Insights for Investors

US | Industrials | Aerospace & Defense | NYSE

Northrop Grumman Corporation (NOC) Bundle

Get Full Bundle:
$18 $12
$18 $12
$18 $12
$18 $12
$25 $15
$18 $12
$18 $12
$18 $12
$18 $12

TOTAL:

You're looking at Northrop Grumman Corporation's stock, wondering if the defense giant's operational strength can overcome program timing risks, and honestly, that's the right question to ask. The latest Q3 2025 results show a powerful bottom-line story, with diluted earnings per share (EPS) hitting $7.67, a 10% jump year-over-year, which allowed management to raise the full-year 2025 MTM-adjusted EPS guidance to a tight range of $25.65 to $26.05. Still, the top-line isn't defintely perfect; while Q3 revenue was $10.42 billion, the full-year revenue guidance was adjusted slightly down to $41.7 billion to $41.9 billion due to program delays, but the crucial free cash flow (FCF) guidance remains rock-solid at $3.05 billion to $3.35 billion. We need to map out how that 1.17 book-to-bill ratio-meaning they are booking more new work than they are billing-translates into sustainable growth for a company with a massive, critical backlog. Let's break down what these numbers truly mean for your investment strategy right now.

Revenue Analysis

You need a clear picture of where Northrop Grumman Corporation (NOC) is actually making its money, especially with the defense sector's current volatility. The direct takeaway is that while the company's overall sales growth is modest, projected between $41.70 billion and $41.90 billion for the 2025 fiscal year, the internal shifts are significant, with Mission Systems and Aeronautics driving the growth while Space Systems faces headwinds.

Northrop Grumman's revenue is primarily generated from two broad categories: Products, which include aircraft, spacecraft, and advanced weapons systems, and Services, encompassing engineering, logistics, and technical support. The vast majority of sales-around 87% in the prior year-come from the U.S. federal government, making it defintely a core dependency.

Segment Contribution and Near-Term Growth

The company is structured into four key business segments. Looking at the most recent granular data from the second quarter of 2025 (Q2 2025), you can see a mixed bag of performance. Total sales for Q2 2025 were $10.4 billion, a modest 1 percent increase year-over-year. The organic sales growth for the full year 2025 is expected to be approximately 3%, which is solid, but not explosive.

Here's the quick math on where the revenue is coming from, based on Q2 2025 segment sales (in millions):

Business Segment Q2 2025 Sales (in millions) YoY Change
Mission Systems $3,157 +14%
Aeronautics Systems $3,114 +2%
Space Systems $2,646 -12%
Defense Systems $1,991 +7%

Mission Systems is your clear winner, posting a strong 14 percent sales increase in Q2 2025, driven by higher volume on marine systems and international ground-based radar programs. Aeronautics is also growing, fueled by the ramp-up of the B-21 Raider and E-130J TACAMO programs. Defense Systems is getting a boost from the Sentinel program and military ammunition orders.

Shifting Revenue Streams: Risks and Opportunities

The biggest change you need to track is the contraction in Space Systems. That segment saw a 12 percent drop in Q2 2025 sales, mainly because of the wind-down of work on certain older space programs. This decline is a near-term headwind, but the company is actively pursuing new opportunities, like the U.S. Space Force contract for satellite refueling technology.

Also, keep an eye on international sales; they grew a significant 18% year-over-year in Q2 2025, showing that global demand for Northrop Grumman's portfolio is rising. This diversification is a good counter-balance to the domestic program shifts. The company's total backlog remains robust at $91.45 billion as of the end of Q3 2025, which gives you visibility on future revenue.

  • Space Systems decline is a known risk.
  • International sales are a major growth opportunity.
  • New programs like B-21 and Sentinel are replacing older revenue.

You can find more on the strategic direction in the Mission Statement, Vision, & Core Values of Northrop Grumman Corporation (NOC). The revenue miss in Q3 2025, despite the earnings beat, shows that sales growth is still the primary challenge, even with a strong backlog.

Profitability Metrics

You need to know if Northrop Grumman Corporation (NOC) is converting its massive defense contracts into real shareholder value, and the short answer is yes, but with a few complexities. The company's profitability is strong, especially its net profit margin, which significantly outperforms the broader defense primes average for 2025.

For the 2025 fiscal year, Northrop Grumman Corporation is projecting total revenue in the range of $41.7 billion to $41.9 billion, which is the top-line driver for all profitability metrics. The key is what falls to the bottom line after all the costs of building B-21 bombers and Sentinel missile systems are factored in. Here's the quick math on where the profits land:

Profitability Metric (FY 2025 Est.) Amount (Est.) Margin (Est./Recent)
Gross Profit $7.949 billion (TTM Sep 2025) ~19.02%
Operating Profit (Segment Operating Income) $4.275 billion - $4.375 billion (Guidance) ~10.35% (Midpoint Est.)
Net Profit ~$4.072 billion (Est.) 9.74% (Q3 2025)

The gross profit margin, at an estimated 19.02%, shows the core business of manufacturing and service delivery is healthy, but this margin has been under pressure over time. Honestly, a declining gross margin is a trend you defintely need to watch, as it suggests rising material or labor costs, or pricing constraints on their contracts. The company's focus on operational efficiency is what's fighting that headwind.

Operational Efficiency and Margin Trends

The trend in Northrop Grumman Corporation's profitability is a story of strong operational management offsetting cost pressures. While the gross margin has seen a gradual erosion in recent years, the company has managed to maintain a solid operating profit margin (Segment Operating Margin) that is expected to be around 10.35% for the full year 2025, based on the midpoint of their Segment Operating Income guidance of $4.325 billion. This is a critical sign that their cost management below the gross profit line-things like R&D and SG&A (Selling, General, and Administrative expenses)-is disciplined.

The net profit margin is the real standout. The reported net margin for the third quarter of 2025 was 9.74%. This figure is a clear indication of efficiency in converting sales into true profit after all expenses, including taxes and interest, are paid. The company's ability to manage its tax rate and non-operating expenses is what keeps this margin high. To understand the strategic goals driving these numbers, you should look at their long-term focus on advanced technology programs like the B-21, which you can read more about here: Mission Statement, Vision, & Core Values of Northrop Grumman Corporation (NOC).

Outperforming the Defense Primes Average

When you stack Northrop Grumman Corporation against the industry, the picture gets even clearer. The average profitability for major defense primes-the industry group Northrop Grumman Corporation belongs to-shows a much tighter squeeze on the bottom line. This comparison highlights a competitive advantage in their contract mix or cost structure.

  • NOC Net Margin (Q3 2025): 9.74%
  • Defense Primes Average Net Margin: ~5.0%

The difference is stark. Northrop Grumman Corporation's net margin is nearly double the industry average. Also, their estimated operating margin of 10.35% is slightly below the broader Defense Primes average of 11.4%. This suggests that while their core operational efficiency (before non-operating items) is competitive, their superior net margin comes from non-operating factors, potentially favorable tax treatment or lower interest expense relative to peers.

What this estimate hides is the impact of large, fixed-price development programs like the B-21, which can cause significant volatility, like the loss provisions seen in early 2025. Still, the overall financial health, as reflected in the high net margin, remains a strong point for investors.

Debt vs. Equity Structure

Northrop Grumman Corporation (NOC) employs a balanced capital structure, but it leans more on debt financing than its peers in the aerospace and defense sector. Your key takeaway is that while the company's debt-to-equity ratio of 0.95 (as of November 2025) is manageable, it sits significantly above the industry average of 0.35, signaling a higher reliance on borrowed capital to fund its operations and growth initiatives. That's a key distinction you need to understand.

The company's financing strategy is clearly visible in its recent financial statements. As of the third quarter of 2025, Northrop Grumman Corporation's long-term debt stood at a substantial $15.162 billion. This is the big number to watch. Short-term debt, which includes the current portion of long-term debt, was approximately $1.1 billion, representing the obligations coming due within the next year. This is a common structure for capital-intensive businesses.

Here's the quick math on the major components of their capital structure from Q3 2025:

Metric Amount (in Billions)
Long-Term Debt $15.162
Current Portion of Long-Term Debt $1.100
Total Shareholders' Equity $15.988

The resulting debt-to-equity (D/E) ratio (total liabilities divided by shareholders' equity) of 0.95 means the company is funding nearly as much of its assets with debt as it is with shareholder capital. What this estimate hides is the strategic use of that debt.

Northrop Grumman Corporation is actively managing its debt maturity profile. In the first quarter of 2025, the company repaid $1.5 billion of long-term debt, which is a strong move to deleverage. However, this was followed in May 2025 by a $1.0 billion public offering of senior unsecured notes, including $500 million of 4.650% notes due 2030 and $500 million of 5.250% notes due 2035.

The proceeds from that May 2025 issuance were earmarked for general corporate purposes, including refinancing existing debt-specifically the higher-interest 7.875% and 7.750% senior notes due 2026-and funding share repurchases. This is a smart financial engineering move: swapping expensive, near-term debt for cheaper, longer-term debt, plus rewarding shareholders. The overall balance sheet is considered solid, and the credit rating was upgraded earlier in 2025, showing lender confidence.

The company balances its debt financing with equity funding through consistent share repurchases and a commitment to its dividend, which was recently increased. This is a common strategy among mature defense contractors: use debt to fund buybacks, which boosts earnings per share (EPS) and shareholder returns, while maintaining a stable, albeit higher-than-average, leverage profile. The D/E ratio of 0.95 is high for the industry, but for a stable, government-backed contractor, it's a calculated risk. You can dive deeper into this analysis in our full blog post: Breaking Down Northrop Grumman Corporation (NOC) Financial Health: Key Insights for Investors.

Liquidity and Solvency

You need to know if Northrop Grumman Corporation (NOC) has enough cash to cover its near-term bills, and the 2025 numbers give us a clear, if slightly nuanced, answer: the liquidity position is adequate, but it relies heavily on efficient working capital management and strong fourth-quarter cash generation.

The core liquidity ratios show a stable but tight position. As of the third quarter of 2025, the Current Ratio sits at approximately 1.11. This means Northrop Grumman Corporation has $1.11 in current assets for every $1.00 in current liabilities. That's above the 1.0 benchmark, which is good, but it's defintely lower than the industry median of 1.89. The Quick Ratio (or acid-test ratio), which strips out inventory-a less liquid asset-is even tighter at about 0.98. This signals that without selling inventory, the company is just shy of covering all its immediate obligations.

Here's the quick math on why that matters:

  • Current Ratio of 1.11: You can pay all short-term debt.
  • Quick Ratio of 0.98: You can almost pay all short-term debt with just cash and receivables.

Analyzing the working capital trends reveals the pressure point. The change in working capital was negative for the first three quarters of 2025, including a significant outflow of -$2.737 billion in the first quarter, followed by -$243 million in Q2 and -$286 million in Q3. This negative trend means the company is using more cash to fund its daily operations-things like paying suppliers or building up inventory for large, complex, long-cycle programs like the B-21 bomber. Rising working capital demands were a primary factor in the year-to-date free cash flow decline through Q2 2025.

The cash flow statement overview shows a pattern typical of defense contractors: a back-end loaded year. Management has reaffirmed and even raised its full-year guidance, now forecasting 2025 Free Cash Flow (FCF) to be between $3.05 billion and $3.35 billion. But what this estimate hides is the Q2 2025 year-to-date FCF, which was a negative $(1,184) million. They are banking on a massive Q4 to hit that target. Net cash from operating activities in Q2 2025 was $868 million, a 39% decrease year-over-year, which reflects the working capital strain.

For investing and financing activities, the trends are clear. Cash flow from investing activities shows a net outflow, with a TTM figure of about -$1.289 billion as of September 2025, primarily due to capital expenditures. On the financing side, the company is actively managing its capital structure and rewarding shareholders. In Q1 2025, Northrop Grumman Corporation repaid $1.5 billion of long-term debt, and they returned over $700 million to shareholders in Q2 alone through buybacks and dividends.

The main strength here is the predictability of revenue from government contracts, which underpins the confidence in the Q4 cash flow recovery. The potential liquidity concern is the reliance on that strong Q4 performance to meet the FCF target, especially given the negative working capital trends in the first three quarters. You can find more context on the long-term strategy that drives these programs here: Mission Statement, Vision, & Core Values of Northrop Grumman Corporation (NOC).

Northrop Grumman Corporation (NOC) Liquidity Snapshot (2025)
Metric Value/Range (2025) Implication
Current Ratio (Q3) 1.11 Adequate short-term coverage, but tight.
Quick Ratio (Q3) 0.98 Slightly insufficient coverage without inventory sales.
Free Cash Flow Guidance (FY) $3.05B - $3.35B Strong full-year projection, but dependent on Q4.
Change in Working Capital (Q1-Q3) Net Outflow (e.g., Q1: -$2.737B) Cash being consumed to fund program growth and inventory.

Your action item is to watch the Q4 2025 earnings release closely for confirmation of the FCF target; if they miss the low end of the $3.05 billion guidance, it signals a deeper structural issue in cash conversion.

Valuation Analysis

You are likely wondering if Northrop Grumman Corporation (NOC) is trading at a fair price right now, especially given the defense sector's current tailwinds. The quick answer is that the stock appears to be trading at a slight premium to its historical averages on a price-to-earnings basis, but analysts still see a clear upside, suggesting it is currently fairly valued with room to run.

As a seasoned financial analyst, I look at three core multiples-Price-to-Earnings (P/E), Price-to-Book (P/B), and Enterprise Value-to-EBITDA (EV/EBITDA)-to gauge its value. Here's the quick math on the trailing twelve months (TTM) data as of mid-November 2025:

  • P/E Ratio: Around 20.08x. This is slightly above the company's five-year average of 18.82x, indicating investors are paying a premium for future earnings, defintely expecting continued stability.
  • EV/EBITDA: Approximately 13.50x. This is above the median of 12.39x over the past 13 years, suggesting the enterprise value, which accounts for debt, is also commanding a higher valuation.
  • P/B Ratio: The ratio stands at about 4.98x. For a capital-intensive defense contractor, this signals that the market values the company at nearly five times its net asset value, which is a significant premium.

The valuation multiples suggest Northrop Grumman Corporation is not cheap, but it's not wildly overvalued either when you consider the sector's growth expectations. What this estimate hides, however, is the long-term nature of defense contracts, which provides revenue predictability that warrants a premium over many other industrial stocks.

Stock Performance and Analyst Outlook

The stock price trend over the last 12 months shows solid momentum, but it has cooled off recently. The stock's closing price around November 17, 2025, was approximately $563.03. Over the past year, the stock's price has increased by about 9.32%. Still, it has pulled back from its 52-week high of $640.90, hit in early October 2025, which gives new investors a better entry point today.

Wall Street analysts are largely bullish, with a consensus rating of 'Moderate Buy' or 'Buy' from the analysts covering the stock. The average twelve-month target price is set at $642.73. This target implies an upside of over 14% from the current price, suggesting the market hasn't fully priced in the expected earnings growth for fiscal year 2025, which the company guided to an EPS range of $25.65 to $26.05.

Dividend Strength and Shareholder Return

For income-focused investors, Northrop Grumman Corporation offers a reliable, growing dividend. The annual dividend per share is currently $9.24, translating to a dividend yield of roughly 1.64%. That yield is competitive within the aerospace and defense industry.

More importantly, the dividend payout ratio is a healthy and sustainable 31.43%. A payout ratio this low means the company is only using about a third of its net earnings to cover the dividend, leaving the remaining two-thirds for reinvestment in new programs, like the B-21 Raider, and for share buybacks. This balance is a sign of financial strength and commitment to returning capital to shareholders while funding future growth. You can dive deeper into who is holding the stock by Exploring Northrop Grumman Corporation (NOC) Investor Profile: Who's Buying and Why?

Risk Factors

You're looking at Northrop Grumman Corporation (NOC) and seeing a strong backlog of $91.45 billion as of Q3 2025, which is defintely a good sign. But in the defense sector, the biggest risks are often hiding inside the largest, most critical programs. We need to focus on where the big dollars are at risk and what management is doing about it.

The core of Northrop Grumman's financial health is tied to two major internal operational risks: the B-21 Raider and the Sentinel Intercontinental Ballistic Missile (ICBM) program. These are multi-billion dollar, long-duration contracts, and any cost overrun hits the bottom line hard.

Here's the quick math on the near-term operational challenges:

  • B-21 Raider Loss Provision: In Q1 2025, the company recognized a pre-tax loss provision of $477 million on the low-rate initial production (LRIP) options. This was due to higher manufacturing costs as they push for an accelerated production ramp.
  • Sentinel ICBM Cost Surge: The estimated total program cost has surged by 81% from its initial projection, now estimated at a colossal $141 billion. This triggered a critical Nunn-McCurdy breach, which means the program is under intense government review.
  • Q3 2025 Revenue Miss: Reported revenue of $10.42 billion fell short of the analyst estimate of $10.72 billion, which is why the full-year sales guidance was slightly lowered to a midpoint of $41.8 billion.

The Sentinel breach introduces significant uncertainty, but the company has secured an agreement on a program restructure, which is a key mitigation step. Also, the Q3 revenue miss, while notable, was offset by strong operational efficiency, which drove segment operating margin to 12.3%, up from 11.5% a year prior. You can read more about the company's market positioning in Exploring Northrop Grumman Corporation (NOC) Investor Profile: Who's Buying and Why?

External Risks and Mitigation Actions

External risks for Northrop Grumman Corporation are less about competition-though that's always a factor with players like Lockheed Martin and Raytheon-and more about the political and economic landscape. The defense industry is heavily dependent on the U.S. Government, which accounts for the vast majority of their sales.

The main external risks and the company's counter-strategies are clear:

Risk Category Specific 2025 Risk Mitigation Strategy / Action
Customer Concentration / Regulatory Dependence on U.S. Government funding resolutions and defense budget. Maintain a record backlog of $91.45 billion and focus on international sales, which grew 18% year-over-year in Q2 2025.
Supply Chain / Operational Lingering supply chain issues affecting production and program schedules. Strategic investments in capacity, like boosting solid rocket motor annual production from 13,000 units today to an expected 25,000 by 2029.
Financial / Market Year-to-date Q2 2025 Free Cash Flow (FCF) decline to $(1,184) million due to cash taxes and working capital. Raised full-year FCF guidance to a range of $3.05 billion to $3.35 billion, reflecting confidence in second-half cash generation and operational improvements.
Portfolio / Strategic Need to optimize the business and focus on core defense technologies. Completed the divestiture of the Training Services business in Q2 2025, resulting in a $231 million pre-tax gain.

Also, don't forget the non-operational financial risks. Changes in actuarial assumptions for their pension and other postretirement benefit plans can swing earnings per share (EPS). For example, the full-year 2025 MTM-adjusted EPS guidance of $25.65 to $26.05 includes a non-operating FAS pension benefit of $545 million below operating income, so you need to keep an eye on those non-core items. The company is actively managing its portfolio and focusing on operational efficiencies to drive profitability, which is a good sign for long-term value, but still, program execution is the biggest risk you're taking here.

Growth Opportunities

You're looking for a clear map of where Northrop Grumman Corporation (NOC) is heading, and the picture is one of targeted, high-tech expansion, even with slight near-term sales adjustments. The core takeaway is that the company is doubling down on its unique technology advantages and a massive, growing backlog, which translates into highly predictable revenue streams.

The company's latest guidance, as of October 2025, reflects this focus on profitability over sheer top-line growth. Northrop Grumman Corporation (NOC) now expects full-year 2025 sales to be between $41.7 billion and $41.9 billion, a modest trim from earlier forecasts, but they simultaneously raised their adjusted earnings per share (EPS) outlook to a range of $25.65 to $26.05. This suggests a more favorable mix of high-margin programs is driving the bottom line. Smart shift.

Here are the key drivers fueling that future growth:

  • B-21 Raider Program: The next-generation stealth bomber is a generational program, giving Northrop Grumman Corporation (NOC) a unique, long-term competitive edge in strategic strike capabilities.
  • International Demand Surge: Geopolitical tensions are translating directly into sales, with international sales growing by 18% year-over-year in the second quarter of 2025.
  • Space and Missile Defense: Growth is strong in Space Systems and Defense Systems, particularly with products like the Integrated Battle Command System (IBCS) and the potential for a large role in the $175 billion Golden Dome missile defense system.

The real engine for future growth is Northrop Grumman Corporation's (NOC) sustained investment and technological edge. They are investing heavily-over 4% of sales-in capital expenditures to expand production capacity for next-generation aircraft, munitions, and propulsion systems. This is well above the industry average, and it's essential for converting their record backlog into revenue. They're not just winning contracts; they're building the factories to deliver them faster.

The table below shows the latest 2025 financial outlook, which is the most critical near-term data for your models:

Metric 2025 Full-Year Guidance (October Update)
Total Sales $41.7 billion to $41.9 billion
Adjusted EPS $25.65 to $26.05 per share
Organic Sales Growth Approximately 3% (Earlier guidance)

What this estimate hides is the strategic shift toward digital engineering and artificial intelligence (AI). Northrop Grumman Corporation (NOC) is using digital engineering to accelerate program schedules and reduce costs, giving them a defintely meaningful advantage in bidding for new work. They've also partnered with Luminary Cloud to speed up AI-driven spacecraft design, positioning them at the forefront of the next wave of defense technology. This focus on advanced microelectronics and AI is a clear moat. For a deeper dive into who is betting on these trends, you should check out Exploring Northrop Grumman Corporation (NOC) Investor Profile: Who's Buying and Why?

The company's competitive advantages are structural, centered on being a key system architect for the U.S. government's most strategic programs. Their diverse portfolio, spanning stealth aircraft, missile defense, and space systems, makes them less vulnerable to a single program cut than some peers. Plus, the record-high backlog of business-reported at $92.8 billion earlier in the year-provides a significant buffer and visibility into cash flow for years to come. That backlog is a solid foundation for long-term value creation.

Next step: Financial analysts should model the impact of the raised EPS guidance, focusing on segment operating margin expansion-especially in Mission Systems and Defense Systems-to see how much of the profit growth is structural versus one-off gains.

DCF model

Northrop Grumman Corporation (NOC) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.